IA
RCUS icon

IndexIQ Advisors’s Arcus Biosciences RCUS Stock Holding History

IndexIQ Advisors’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-15,090
Closed -$392K – 1283
2020
Q4 		$392K Buy
15,090
+1,558
+12% +$37.7K 0.01% 499
2020
Q3 		$232K Buy
13,532
+733
+6% +$16.4K 0.01% 536
2020
Q2 		$317K Sell
12,799
-1,246
-9% -$33.6K 0.01% 322
2020
Q1 		$195K Buy
+14,045
New +$175K 0.01% 340

Other funds holding RCUS

AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
IFA
Invus Financial Advisors New York $89.2M AUM 10.79% 1-Year Est. Return

IndexIQ Advisors's RCUS Position: Q1 2021 in Review

IndexIQ Advisors sold out of Arcus Biosciences (RCUS) in Q1 2021, closing a stake of 15,090 shares — an estimated $392K sold.

IndexIQ Advisors first reported a position in RCUS in Q1 2020 and held it in 4 quarters. The position peaked at $392K in Q4 2020. 148 funds tracked by Wall St. Rank hold RCUS as of Q1 2021.

  • IndexIQ Advisors reported no remaining Arcus Biosciences position as of Q1 2021 after selling out during the quarter.
  • IndexIQ Advisors sold 15,090 Arcus Biosciences shares in Q1 2021, an estimated $392K.
  • IndexIQ Advisors first reported a position in Arcus Biosciences in Q1 2020 and held it in 4 quarters.
  • IndexIQ Advisors's Arcus Biosciences position peaked at $392K in Q4 2020.
  • 148 funds tracked by Wall St. Rank held Arcus Biosciences as of Q1 2021.

Based on IndexIQ Advisors's 13F filing for Q1 2021, filed 7 May 2021.